Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2000 1
2002 1
2003 1
2005 2
2007 2
2008 3
2009 5
2010 3
2011 5
2012 3
2013 5
2014 8
2015 8
2016 5
2017 6
2018 4
2019 4
2020 11
2021 26
2022 29
2023 17
2024 19
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.
Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A. Corti D, et al. Among authors: temperton n. Science. 2011 Aug 12;333(6044):850-6. doi: 10.1126/science.1205669. Epub 2011 Jul 28. Science. 2011. PMID: 21798894
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.
Paciello I, Pierleoni G, Pantano E, Antonelli G, Pileri P, Maccari G, Cardamone D, Realini G, Perrone F, Neto MM, Pozzessere S, Fabbiani M, Panza F, Rancan I, Tumbarello M, Montagnani F, Medini D, Maes P, Temperton N, Simon-Loriere E, Schwartz O, Rappuoli R, Andreano E. Paciello I, et al. Among authors: temperton n. Cell Rep. 2024 Sep 24;43(9):114645. doi: 10.1016/j.celrep.2024.114645. Epub 2024 Aug 27. Cell Rep. 2024. PMID: 39207904 Free PMC article.
Pseudotyped Viruses for Influenza.
Del Rosario JMM, da Costa KAS, Temperton NJ. Del Rosario JMM, et al. Among authors: temperton nj. Adv Exp Med Biol. 2023;1407:153-173. doi: 10.1007/978-981-99-0113-5_8. Adv Exp Med Biol. 2023. PMID: 36920696
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration.
Beukenhorst AL, Frallicciardi J, Rice KL, Koldijk MH, Moreira de Mello JC, Klap JM, Hadjichrysanthou C, Koch CM, da Costa KAS, Temperton N, de Jong BA, Vietsch H, Ziere B, Julg B, Koudstaal W, Goudsmit J. Beukenhorst AL, et al. Among authors: temperton n. Sci Rep. 2024 Feb 15;14(1):3818. doi: 10.1038/s41598-024-53049-5. Sci Rep. 2024. PMID: 38360813 Free PMC article.
Human seasonal coronavirus neutralization and COVID-19 severity.
Wells DA, Cantoni D, Mayora-Neto M, Genova CD, Sampson A, Ferrari M, Carnell G, Nadesalingam A, Smith P, Chan A, Raddi G, Castillo-Olivares J, Baxendale H, Temperton N, Heeney JL. Wells DA, et al. Among authors: temperton n. J Med Virol. 2022 Oct;94(10):4820-4829. doi: 10.1002/jmv.27937. Epub 2022 Jul 18. J Med Virol. 2022. PMID: 35705514 Free PMC article.
Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses.
Huang CQ, Hills RA, Carnell GW, Vishwanath S, Aguinam ET, Chan ACY, Palmer P, O'Reilly L, Tonks P, Temperton N, Frost SDW, Tiley LS, Howarth MR, Heeney JL. Huang CQ, et al. Among authors: temperton n. Emerg Microbes Infect. 2025 Dec;14(1):2511132. doi: 10.1080/22221751.2025.2511132. Epub 2025 Jul 11. Emerg Microbes Infect. 2025. PMID: 40476519 Free PMC article.
Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity.
Bruno LA, Pueblas Castro C, Demaría A, Prado L, Fascetto Cassero CG, Saposnik LM, Páez Córdoba F, Rodriguez JM, Piccini G, Antonelli R, Lapini G, Temperton N, Del Priore SA, Hernando Insua AC, Kaufmann IG, Vega JC, Flo JM, Pasquevich KA, Coria LM, Cassataro J. Bruno LA, et al. Among authors: temperton n. NPJ Vaccines. 2025 May 29;10(1):108. doi: 10.1038/s41541-025-01156-3. NPJ Vaccines. 2025. PMID: 40442110 Free PMC article.
Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD.
Olivier J, George C, Huang CQ, Sujit SB, Tonks P, Cantoni D, Grove J, O'Reilly L, Geiger J, Dohmen C, Mummert V, Samuel AR, Plank C, Kinsley R, Temperton N, Pfranger M, Wagner R, Heeney JL, Vishwanath S, Carnell GW. Olivier J, et al. Among authors: temperton n. Emerg Microbes Infect. 2025 Dec;14(1):2502011. doi: 10.1080/22221751.2025.2502011. Epub 2025 May 20. Emerg Microbes Infect. 2025. PMID: 40326334 Free PMC article.
170 results